Integer Holdings Corp., Plano, Texas, announced that it will further expand its presence in Ireland with the construction of a new medical device innovation and manufacturing facility in the Parkmore East area of Galway.
This new facility is required to meet increased demand for regional research, development, and manufacturing capabilities as well as capacity for catheters and delivery systems. It adds to Integer’s 15 global manufacturing sites and current presence in Ireland, which includes an R&D center in Galway and manufacturing facilities in Galway and New Ross, County Wexford.
The initial phase of the project will include the construction of a 60,000 square foot facility on land purchased from IDA Ireland and involves a projected $30 million investment over the next several years. Construction is anticipated to kick off in 2022, with estimated completion in late 2023. Once complete, all-new regional research, development, and manufacturing will be housed in this facility, with equipment investments continuing over the following 2-3 years. This initial phase will satisfy Integer’s immediate space requirements in the region; however, the company has obtained planning permission for a total of 147,000 square feet for future expansion when needed.
Read further here.
